Stocktitan

Published September 15, 2026

Ensysce Biosciences Joins FDA Psychedelic Drug Hearing | ENSC Stock News

Read the full story at Stocktitan

Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic ... Ensysce Biosciences is a clinical-stage.